Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats

Journal of Gastrointestinal Surgery

Volumn 14, Issue 3, 2010, Pages 528-535

  Behrends, Matthias ^a   Martinez Palli, Graciela ^b   Niemann, Claus U ^a   Cohen, Sara ^a   Ramachandran, Rageshree ^a   Hirose, Ryutaro ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Inflammatory response; Liver; Metabolism; Neutrophils; Surgery

Indexed keywords

ALANINE AMINOTRANSFERASE; HEAT SHOCK PROTEIN;

ACUTE DISEASE; ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; LEWIS RAT; LIVER DISEASE; LIVER FUNCTION TEST; MALE; METABOLISM; MORTALITY; NEEDLE BIOPSY; NEUTROPHIL CHEMOTAXIS; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; BIOPSY, NEEDLE; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEAT-SHOCK PROTEINS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; NEUTROPHIL INFILTRATION; OXIDATIVE STRESS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SURVIVAL RATE;

EID: 77950518419     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1112-3     Document Type: Article

References (28)

1. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005; 130: 1144.
2. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-982.
3. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
4. van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.
5. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, van Etten E, Herijgers P, Mathieu C, van den Berghe G. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 2006; 55: 1096-1105.
6. Martin A, Rojas S, Chamorro A, Falcon C, Bargallo N, Planas AM. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke 2006; 37: 1288-1295.
7. Hirose R, Xu F, Dang K, Liu T, Behrends M, Brakeman PR, Wiener-Kronish J, Niemann CU. Transient hyperglycemia affects the extent of ischemia-reperfusion-induced renal injury in rats. Anesthesiology 2008; 108: 402-414.
8. Ling PR, Mueller C, Smith RJ, Bistrian BR. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism 2003; 52: 868-874.
9. Iwasaki Y, Kambayashi M, Asai M, Yoshida M, Nigawara T, Hashimoto K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J Diabetes Complications 2007; 21: 56-62.
10. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997; 95: 1783-1790.
11. Rogers H 3rd, Zibari GB, Roberts J, Turnage R, Lefer DJ. Nitric oxide attenuates ischaemia-reperfusion (I/R) injury in the diabetic liver. Clin Transplant 2004; 18(Suppl 12): 7-11.
12. Elrod JW, Duranski MR, Langston W, Greer JJ, Tao L, Dugas TR, Kevil CG, Champion HC, Lefer DJ. eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling. Circ Res 2006; 99: 78-85.
13. Suzuki S, Nakamura S, Koizumi T, Sakaguchi S, Baba S, Muro H, Fujise Y. The beneficial effect of a prostaglandin I2 analog on ischemic rat liver. Transplantation 1991; 52: 979-983.
14. Saraste A. Morphologic criteria and detection of apoptosis. Herz 1999; 24: 189-195.
15. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-1105.
16. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397-405.
17. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257.
18. Brix-Christensen V, Gjedsted J, Andersen SK, Vestergaard C, Nielsen J, Rix T, Nyboe R, Andersen NT, Larsson A, Schmitz O, Tonnesen E. Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs. Acta Anaesthesiol Scand 2005; 49: 991-998.
19. Raina AK, Perry G, Nunomura A, Sayre LM, Smith MA. Histochemical and immunocytochemical approaches to the study of oxidative stress. Clin Chem Lab Med 2000; 38: 93-97.
20. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991; 260: G355-362.
21. Ling PR, Smith RJ, Bistrian BR. Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in rats. Crit Care Med 2005; 33: 1084-1089.
22. Muranyi M, He QP, Fong KS, Li PA. Induction of heat shock proteins by hyperglycemic cerebral ischemia. Brain Res Mol Brain Res 2005; 139: 80-87.
23. Yamagishi N, Nakayama K, Wakatsuki T, Hatayama T. Characteristic changes of stress protein expression in streptozotocin-induced diabetic rats. Life Sci 2001; 69: 2603-2609.
24. Najemnikova E, Rodgers CD, Locke M. Altered heat stress response following streptozotocin-induced diabetes. Cell Stress Chaperones 2007; 12: 342-352.
25. Swiecki C, Stojadinovic A, Anderson J, Zhao A, Dawson H, Shea-Donohue T. Effect of hyperglycemia and nitric oxide synthase inhibition on heat tolerance and induction of heat shock protein 72 kDa in vivo. Am Surg 2003; 69: 587-592.
26. Santoro MG. Heat shock factors and the control of the stress response. Biochem Pharmacol 2000; 59: 55-63.
27. Hooper PL. Insulin signaling, GSK-3, heat shock proteins and the natural history of type 2 diabetes mellitus: a hypothesis. Metab Syndr Relat Disord 2007; 5: 220-230.
28. Kavanagh K, Zhang L, Wagner JD. Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys. Cell Stress Chaperones 2009; 14: 291-299.